CanLiv Leadership

 

Melanie B. Thomas, MD
President, CanLiv
Associate Director of Clinical Investigations,
Hollings Cancer Center
Grace E. DeWolff Chair of Medical Oncology
Associate Professor, Hollings Cancer Center, Medical University of South Carolina
Charleston, SC
Medical oncologist who specializes in treatment of and clinical research for patients with cancers of the bile ducts, gallbladder and liver.

Melvyn H. Blum
Treasurer, CanLiv
New York City, NY
Family member of individual affected by hepatobiliary cancer

Matthew V. Byrne III, Esq
Secretary, CanLiv
Byrne, Costello, and Pickard, P.C.
Syracuse, NY
Attorney with extensive expertise in establishing philanthropic organizations

Peter Shamamian, MD
Board Member, CanLiv
Chief of Surgery, Department of Veteran Affairs
Professor, Department of Surgery, Medical University of South Carolina
Charleston, SC
Surgical oncologist who specializes in treatment of and research for patients with cancers of the bile ducts, liver and pancreas.

 

Andrew X. Zhu, MD, PhD
Vice President, CanLiv
Director, Liver Cancer Research
Massachusettes General Hospital Cancer Center
Boston, MA
Medical oncologist who specializes in treatment of and clinical research for patients with cancers of the bile ducts, gallbladder and liver.